Compare GIL & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GIL | ASND |
|---|---|---|
| Founded | 1946 | 2006 |
| Country | Canada | Denmark |
| Employees | N/A | N/A |
| Industry | Building Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 13.6B |
| IPO Year | 1999 | 2014 |
| Metric | GIL | ASND |
|---|---|---|
| Price | $59.48 | $230.34 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 15 |
| Target Price | $78.00 | ★ $278.80 |
| AVG Volume (30 Days) | ★ 1.6M | 718.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 1.50% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $76.47 | $98.02 |
| Revenue Next Year | $4.88 | $43.13 |
| P/E Ratio | $23.11 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $39.28 | $124.06 |
| 52 Week High | $73.70 | $248.60 |
| Indicator | GIL | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 26.15 | 49.46 |
| Support Level | $59.09 | $190.49 |
| Resistance Level | $62.40 | $245.30 |
| Average True Range (ATR) | 1.91 | 9.40 |
| MACD | -1.23 | -0.89 |
| Stochastic Oscillator | 4.54 | 35.92 |
Gildan is a vertically integrated designer and manufacturer of basic apparel, including T-shirts, underwear, socks, and hosiery. Its primary market is the sale of blank T-shirts, sweatshirts, and other apparel to wholesalers, major clothing brands, and printers (printwear). Gildan also sells branded clothing through retail and direct-to-consumer channels. Brands include Gildan, American Apparel, Comfort Colors, and Goldtoe. Gildan produces most of its clothing at factories in Latin America but has been ramping up production at its new facility in Bangladesh. Incorporated in 1984, the Montreal-based company operates internationally but generates nearly 90% of its sales in the US. Gildan is acquiring its US rival Hanesbrands to bolster its consumer and printwear operations.
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.